AESCULUS HIPPOCASTANUM pellet

Land: USA

Språk: engelska

Källa: NLM (National Library of Medicine)

Aktiva substanser:

HORSE CHESTNUT (UNII: 3C18L6RJAZ) (HORSE CHESTNUT - UNII:3C18L6RJAZ)

Tillgänglig från:

Hahnemann Laboratories, Inc.

Administreringssätt:

ORAL

Receptbelagda typ:

OTC DRUG

Bemyndigande status:

unapproved homeopathic

Produktens egenskaper

AESCULUS HIPPOCASTANUM- AESCULUS HIPPOCASTANUM PELLET
HAHNEMANN LABORATORIES, INC.
_Disclaimer: This homeopathic product has not been evaluated by the
Food and Drug Administration for_
_safety or efficacy. FDA is not aware of scientific evidence to
support homeopathy as effective._
----------
AESCULUS HIPPOCASTANUM
aesculus hippocastanum pellet
PRODUCT INFORMATION
PRODUCT T YPE
HUMAN OTC DRUG
ITE M CODE (SOURCE )
NDC:6 3545-756
ROUTE OF ADMINISTRATION
ORAL
ACTIVE INGREDIENT/ACTIVE MOIETY
INGREDIENT NAME
BASIS OF STRENGTH
STRE NG TH
HO RSE CHESTNUT (UNII: 3C18 L6 RJAZ) (HORSE CHESTNUT - UNII:3C18 L6
RJAZ)
HORSE CHESTNUT
20 0 [hp_C]
INACTIVE INGREDIENTS
INGREDIENT NAME
STRE NG TH
SUCRO SE (UNII: C151H8 M554)
PRODUCT CHARACTERISTICS
COLOR
white
S CORE
no sco re
S HAP E
ROUND
S IZ E
2mm
FLAVOR
IMPRINT CODE
CONTAINS
PACKAG ING
#
ITEM CODE
PACKAGE DESCRIPTION
MARKETING START
DATE
MARKETING END
DATE
1
NDC:6 3545-756 -
0 1
20 0 in 1 VIAL, GLASS; Type 0 : No t a Co mbinatio n Pro duct
0 1/14/20 20
2
NDC:6 3545-756 -
0 2
50 0 in 1 VIAL, GLASS; Type 0 : No t a Co mbinatio n Pro duct
0 1/14/20 20
3
NDC:6 3545-756 -
0 3
30 0 0 in 1 BOTTLE, GLASS; Type 0 : No t a Co mbinatio n
Pro duc t
0 1/14/20 20
4
NDC:6 3545-756 -
0 4
10 0 0 0 in 1 BOTTLE, GLASS; Type 0 : No t a Co mbinatio n
Pro duc t
0 1/14/20 20
MARKETING INFORMATION
MARKE TING CATE GORY
APPLICATION NUMBE R OR MONOGRAPH CITATION
MARKE TING START DATE
MARKE TING END DATE
unappro ved ho meo pathic
0 1/14/20 20
LABELER -
Hahnemann Laboratories, Inc. (147098081)
ESTABLISHMENT
NAME
AD D RE S S
ID/FEI
BUSINE SS OPE RATIONS
Hahnemann Labo rato ries, Inc.
1470 9 8 0 8 1
ma nufa c ture (6 3545-756 )
Hahnemann Laboratories, Inc.
Revised: 1/2020